Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Kalow

Showing results (181-190 of 188) with videos related to

Pageof 19
Sort By:
You have reached the last page of results.This site can display upto 188 results.
Pharmacogenetics|October 1, 1991
Identification of a new variant CYP2D6 allele lacking the codon encoding Lys-281: possible association with the poor metabolizer phenotypeR Tyndale, T Aoyama, F Broly, et al.
Environmental Health Perspectives|November 1, 1990
The caffeine breath test and caffeine urinary metabolite ratios in the Michigan cohort exposed to polybrominated biphenyls: a preliminary studyG H Lambert, D A Schoeller, H E Humphrey, et al.
Biochemistry|September 5, 1989
cDNA cloning and sequence and cDNA-directed expression of human P450 IIB1: identification of a normal and two variant cDNAs derived from the CYP2B locus on chromosome 19 and differential expression of the IIB mRNAs in human liverS Yamano, P T Nhamburo, T Aoyama, et al.
The Journal of Biological Chemistry|June 25, 1989
Cytochrome P-450 hPCN3, a novel cytochrome P-450 IIIA gene product that is differentially expressed in adult human liver. cDNA and deduced amino acid sequence and distinct specificities of cDNA-expressed hPCN1 and hPCN3 for the metabolism of steroid hormones and cyclosporineT Aoyama, S Yamano, D J Waxman, et al.
Journal of Clinical Psychopharmacology|January 5, 2002
Treatment-resistance to clozapine in association with ultrarapid CYP1A2 activity and the C-->A polymorphism in intron 1 of the CYP1A2 gene: effect of grapefruit juice and low-dose fluvoxamineV Ozdemir, W Kalow, A B Okey, et al.
Journal of Clinical Psychopharmacology|July 31, 2001
CYP1A2 activity as measured by a caffeine test predicts clozapine and active metabolite steady-state concentrationin patients with schizophreniaV Ozdemir, W Kalow, P Posner, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 18, 1998
Serotonin subtype 2 receptor genes and clinical response to clozapine in schizophrenia patientsM Masellis, V Basile, H Y Meltzer, et al.
Molecular Psychiatry|July 13, 2000
A functional polymorphism of the cytochrome P450 1A2 (CYP1A2) gene: association with tardive dyskinesia in schizophreniaV S Basile, V Ozdemir, M Masellis, et al.
Pageof 19

Showing results (181-190 of 188) with videos related to

Sort By:
Pageof 19
You have reached the last page of results.This site can display upto 188 results.
Pharmacogenetics|October 1, 1991
Identification of a new variant CYP2D6 allele lacking the codon encoding Lys-281: possible association with the poor metabolizer phenotypeR Tyndale, T Aoyama, F Broly, et al.
Environmental Health Perspectives|November 1, 1990
The caffeine breath test and caffeine urinary metabolite ratios in the Michigan cohort exposed to polybrominated biphenyls: a preliminary studyG H Lambert, D A Schoeller, H E Humphrey, et al.
Biochemistry|September 5, 1989
cDNA cloning and sequence and cDNA-directed expression of human P450 IIB1: identification of a normal and two variant cDNAs derived from the CYP2B locus on chromosome 19 and differential expression of the IIB mRNAs in human liverS Yamano, P T Nhamburo, T Aoyama, et al.
The Journal of Biological Chemistry|June 25, 1989
Cytochrome P-450 hPCN3, a novel cytochrome P-450 IIIA gene product that is differentially expressed in adult human liver. cDNA and deduced amino acid sequence and distinct specificities of cDNA-expressed hPCN1 and hPCN3 for the metabolism of steroid hormones and cyclosporineT Aoyama, S Yamano, D J Waxman, et al.
Journal of Clinical Psychopharmacology|January 5, 2002
Treatment-resistance to clozapine in association with ultrarapid CYP1A2 activity and the C-->A polymorphism in intron 1 of the CYP1A2 gene: effect of grapefruit juice and low-dose fluvoxamineV Ozdemir, W Kalow, A B Okey, et al.
Journal of Clinical Psychopharmacology|July 31, 2001
CYP1A2 activity as measured by a caffeine test predicts clozapine and active metabolite steady-state concentrationin patients with schizophreniaV Ozdemir, W Kalow, P Posner, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 18, 1998
Serotonin subtype 2 receptor genes and clinical response to clozapine in schizophrenia patientsM Masellis, V Basile, H Y Meltzer, et al.
Molecular Psychiatry|July 13, 2000
A functional polymorphism of the cytochrome P450 1A2 (CYP1A2) gene: association with tardive dyskinesia in schizophreniaV S Basile, V Ozdemir, M Masellis, et al.
Pageof 19